Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Interferon A
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Interferon alfa-2a 18million units/0.5ml inj pfs
0802040J0AABGBG
|
Interferon A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Interferon alfa-2a 18million units/0.6ml inj cartridges
0802040J0AABFBF
|
Interferon A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Interferon alfa-2a 3million units/0.5ml inj pfs
0802040J0AAAVAV
|
Interferon A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Interferon alfa-2a 4.5million units/0.5ml inj pfs
0802040J0AAAWAW
|
Interferon A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Interferon alfa-2a 6million units/0.5ml inj pfs
0802040J0AAAXAX
|
Interferon A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Interferon alfa-2a 9million units/0.5ml inj pfs
0802040J0AAAYAY
|
Interferon A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Interferon alfa-2b 10million unit inj vials
0802040J0AAAHAH
|
Interferon A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Interferon alfa-2b 18million units/1.2ml inj pf dispos dev
0802040J0AABBBB
|
Interferon A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Interferon alfa-2b 18million units/3ml inj vials
0802040J0AAAUAU
|
Interferon A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Interferon alfa-2b 1million unit inj vials
0802040J0AAAKAK
|
Interferon A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Interferon alfa-2b 25million units/2.5ml inj multidose vials
0802040J0AABEBE
|
Interferon A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Interferon alfa-2b 30million units/1.2ml inj pf dispos dev
0802040J0AABCBC
|
Interferon A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Interferon alfa-2b 3million unit inj vials
0802040J0AAAGAG
|
Interferon A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
|
Interferon alfa-2b 60million units/1.2ml inj pf dispos dev
0802040J0AABDBD
|
Interferon A | Interferon alpha | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.